Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Blis confirms Asia-Pacific and Africa distribution agreement

Blis Technologies confirms Asia-Pacific and Africa distribution agreement with iNova Pharmaceuticals

7 September 2018 | Dunedin, New Zealand

Blis Technologies Limited today confirmed it has entered into a distribution agreement with iNova Pharmaceuticals (Singapore) Pte Ltd for the distribution of BLIS branded products. iNova Pharmaceuticals is a multinational pharmaceutical and consumer health care company that markets and sells a wide range of market-leading products in over 20 countries across Asia-Pacific and Africa.

The agreement will provide iNova Pharmaceuticals with exclusive distribution rights for BLIS branded products across Australia, Sub-Saharan Africa, and Asia based on a commitment of resources to support product launches. iNova Pharmaceutical’s presence in pharmacy retail provides a strong platform for the launch of BLIS branded products into overseas markets.

The initial focus will be on launch plans for the Australian market where BLIS K12 has achieved inclusion in TGA’s Therapeutic Goods (Permissible Ingredients) Determination for use in listed complementary medicines, allowing stronger positioning of the BLIS portfolio.

Blis CEO Brian Watson says that this agreement is another important step in the company’s finished product strategy.

“iNova Pharmaceuticals has a strong presence in the pharmacy channel and a proven track record of establishing category-leading brands in consumer health care. Working with a partner of this calibre will provide the right capability and resourcing to effectively establish BLIS branded products in multiple markets across the iNova Pharmaceuticals network. Our focus initially will be to finalise our plans for the Australian market but also to progress launch plans for other markets across Asia and Africa”

The agreement builds on the success of Blis Technologies’ new distribution relationship in New Zealand with Radiant Health, which also holds the distribution rights for the iNova Pharmaceuticals product range locally. Radiant has demonstrated its ability to leverage its presence in the market to help grow the BLIS range.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Manawatu-Whanganui Projects: PGF Top-Up To Rural Broadband Roll-Out

The government has effectively raided the $3 billion Provincial Growth Fund to top up the budget for the second phase of its rural broadband initiative, filling in mobile 'black spots' and ensuring broadband is available to marae that don't have access now. More>>

ALSO:

Other Windy Cities: Auckland-Chicago Named A Top 10 ‘Most Exciting’ New Route

The inclusion of Auckland-Chicago on Lonely Planet’s Where to fly in 2019? The 10 most exciting new flight routes list comes just two weeks before Air New Zealand prepares to celebrate its inaugural flight to Chicago’s O’Hare International Airport on 30 November. More>>

Deadly Strain: ESR Ups Its Reporting On Meningococcal Disease

The increasing number of cases of Group W Meningococcal disease (MenW) has prompted ESR to increase its reporting on the disease to the Ministry of Health. ESR has upped its reporting to weekly. More>>

ALSO:

Very Small Things: "Game-Changing" 3D Printing Technology Launched

New Zealand microfabrication researchers Andrea Bubendorfer and Andrew Best, the co-inventors of a new way of fabricating very small things with Laminated Resin Printing (LRP), are part of Callaghan Innovation’s MicroMaker3D team launching the new patent pending technology in the US this week. More>>

ALSO: